Stock Track | Moderna Stock Plummets 5.05% Intraday Following Departure of Key COVID Vaccine Executive

Stock Track01-31

Moderna, Inc. (MRNA) shares experienced a significant intraday decline of 5.05% on Friday. The sharp drop followed news of a major leadership change at the biotechnology company.

The movement was triggered by the announcement that Chief Medical Officer Dr. Jacqueline Miller will step down from her role effective March 2. Miller, who joined Moderna in 2020, led the development of the company's mRNA-based COVID-19 vaccine Spikevax and has been instrumental in multiple vaccine approvals. Her departure comes at a critical time as Moderna seeks to address declining revenue from COVID products and expand its mRNA platform into a broader franchise.

Moderna has named David Berman, formerly of Immunocore, as Chief Development Officer beginning March 2. Miller will remain as a consultant to assist with the transition. The executive change appears to have shaken investor confidence, contributing to the stock's downward pressure during the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108315648?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-31 00:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108315648","market":"us","top_or_hot":-1,"title":"Stock Track | Moderna Stock Plummets 5.05% Intraday Following Departure of Key COVID Vaccine Executive","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) shares experienced a significant intraday decline of 5.05% on Friday. The sharp drop followed news of a major leadership change at the biotechnology company.</p>\n<p>The movement was triggered by the announcement that Chief Medical Officer Dr. Jacqueline Miller will step down from her role effective March 2. Miller, who joined Moderna in 2020, led the development of the company's mRNA-based COVID-19 vaccine Spikevax and has been instrumental in multiple vaccine approvals. Her departure comes at a critical time as Moderna seeks to address declining revenue from COVID products and expand its mRNA platform into a broader franchise.</p>\n<p>Moderna has named David Berman, formerly of Immunocore, as Chief Development Officer beginning March 2. Miller will remain as a consultant to assist with the transition. The executive change appears to have shaken investor confidence, contributing to the stock's downward pressure during the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Stock Plummets 5.05% Intraday Following Departure of Key COVID Vaccine Executive</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Stock Plummets 5.05% Intraday Following Departure of Key COVID Vaccine Executive\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-31 00:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) shares experienced a significant intraday decline of 5.05% on Friday. The sharp drop followed news of a major leadership change at the biotechnology company.</p>\n<p>The movement was triggered by the announcement that Chief Medical Officer Dr. Jacqueline Miller will step down from her role effective March 2. Miller, who joined Moderna in 2020, led the development of the company's mRNA-based COVID-19 vaccine Spikevax and has been instrumental in multiple vaccine approvals. Her departure comes at a critical time as Moderna seeks to address declining revenue from COVID products and expand its mRNA platform into a broader franchise.</p>\n<p>Moderna has named David Berman, formerly of Immunocore, as Chief Development Officer beginning March 2. Miller will remain as a consultant to assist with the transition. The executive change appears to have shaken investor confidence, contributing to the stock's downward pressure during the trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1108315648","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108315648","pubTimestamp":1769789003,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (MRNA) shares experienced a significant intraday decline of 5.05% on Friday. The sharp drop followed news of a major leadership change at the biotechnology company. The movement was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股追踪|新冠疫苗关键高管离职Moderna股价盘中暴跌5.05%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) shares experienced a significant intraday decline of 5.05% on Friday. The sharp drop followed news of a major leadership change at the biotechnology company.\nThe movement was triggered by the announcement that Chief Medical Officer Dr. Jacqueline Miller will step down from her role effective March 2. Miller, who joined Moderna in 2020, led the development of the company's mRNA-based COVID-19 vaccine Spikevax and has been instrumental in multiple vaccine approvals. Her departure comes at a critical time as Moderna seeks to address declining revenue from COVID products and expand its mRNA platform into a broader franchise.\nModerna has named David Berman, formerly of Immunocore, as Chief Development Officer beginning March 2. Miller will remain as a consultant to assist with the transition. The executive change appears to have shaken investor confidence, contributing to the stock's downward pressure during the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108315648","isCrawlerRequest":true}